Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
- Resource Type
- Article
- Authors
- Keck, Michaela-Kristina; Sill, Martin; Wittmann, Andrea; Joshi, Piyush; Stichel, Damian; Beck, Pengbo; Okonechnikow, Konstantin; Sievers, Philipp; Wefers, Annika K.; Roncaroli, Federico; Avula, Shivaram; McCabe, Martin G.; Hayden, James T.; Wesseling, Pieter; Øra, Ingrid; Nistér, Monica; Kranendonk, Mariëtte E. G.; Tops, Bastiaan B. J.; Zapotocky, Michal; Zamecnik, Josef
- Source
- Acta Neuropathologica. Apr2023, Vol. 145 Issue 4, p511-514. 4p.
- Subject
- *GENE amplification
*TUMORS
*LOG-rank test
*TUMOR suppressor genes
- Language
- ISSN
- 0001-6322
Correction to: Amplification of the PLAG-family genes - PLAGL1 and PLAGL2 - is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification 6 Clinical outcomes of patients with CNS embryonal tumor with PLAGL gene amplification. a Kaplan-Meier plots showing OS and PFS stratified by subgroup and sex. Information about chemotherapy (CT) and radiotherapy (RT) treatment regarding the entire follow-up time is displayed in the squares on the left where available The original article has been corrected. [Extracted from the article]